| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Investigations |
Division of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
The purpose of this study was to evaluate the ability of 18F-FDG PET to characterize adrenal lesions in patients with proven or suspected cancers. Methods: A retrospective analysis was performed on 50 adrenal lesions in 41 patients, whose PET scans were done to evaluate the primary or metastatic disease. CT had shown 50 adrenal lesions in 41 patients and MRI had revealed 13 lesions in 10 patients. There were 34 patients with proven malignancy (28 lung cancer, 3 thyroid cancer, 2 colorectal cancer, and 1 lymphoma) and 7 with lung nodules. Of the 50 lesions, 18 were eventually determined to be malignant either by histopathology (n = 7) or by follow-up (n = 11). The remaining 32 lesions were proven or assumed to be benign by histopathology (n = 4) or clinical follow-up (n = 28). Unlike previously published reports, PET was interpreted as positive if the uptake was equal to or greater than that of the liver. Results: No malignant lesion yielded a negative result on PET. Most lesions (13/18) showed significantly higher FDG uptake than that of the liver. In the remaining 5 lesions (2 metastases from neuroendocrine tumor, 2 early metastases, and 1 necrotic metastasis), FDG uptake was equal to or slightly higher than that of the liver. Of the 32 benign lesions, there were 2 lesions with uptake equal to or slightly higher than that of the liver, 3 with uptake less than the liver but more than the background, and 27 with uptake of the background. MRI identified 3 of the 13 lesions as false-positives but FDG PET correctly identified all 3 as benign. The other 10 adrenal lesions accurately diagnosed by MRI were also characterized by PET. FDG PET for characterization of adrenal lesions showed a sensitivity of 100%, a specificity of 94%, and an accuracy of 96%. Conclusion: FDG PET showed excellent diagnostic performance in differentiating adrenal lesions detected on CT or MRI. Because FDG PET has the additional advantage of evaluating the primary lesions as well as metastases, it could be cost-effective and the modality of choice for the characterization of adrenal lesions, especially in patients with malignancy.
Key Words: adrenal gland • tumor • 18F-FDG PET
This article has been cited by other articles:
|
|
 |
|
  A. B. Elaini, S. K. Shetty, V. M. Chapman, D. V. Sahani, G. W. Boland, A. T. Sweeney, M. M. Maher, J. T. Slattery, P. R. Mueller, and M. A. Blake Improved Detection and Characterization of Adrenal Disease with PET-CT RadioGraphics, May 1, 2007; 27(3): 755 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. F. Young Jr. The Incidentally Discovered Adrenal Mass N. Engl. J. Med., February 8, 2007; 356(6): 601 - 610. [Full Text] [PDF]
|
|
|
|
 |
|
 I. C. Mitchell and F. E. Nwariaku Adrenal Masses in the Cancer Patient: Surveillance or Excision Oncologist, February 1, 2007; 12(2): 168 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chong, K. S. Lee, H. Y. Kim, Y. K. Kim, B.-T. Kim, M. J. Chung, C. A Yi, and G. Y. Kwon Integrated PET-CT for the Characterization of Adrenal Gland Lesions in Cancer Patients: Diagnostic Efficacy and Interpretation Pitfalls RadioGraphics, November 1, 2006; 26(6): 1811 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Intenzo, K. S. Lee, and B.-T. Kim Invited Commentary * Authors' Response RadioGraphics, November 1, 2006; 26(6): 1824 - 1826. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Blake, A. Singh, B. N. Setty, J. Slattery, M. Kalra, M. M. Maher, D. V. Sahani, A. J. Fischman, and P. R. Mueller Pearls and Pitfalls in Interpretation of Abdominal and Pelvic PET-CT RadioGraphics, September 1, 2006; 26(5): 1335 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Mackie, B. L. Shulkin, R. C. Ribeiro, F. P. Worden, P. G. Gauger, R. J. Mody, L. P. Connolly, G. Kunter, C. Rodriguez-Galindo, J. W. Wallis, et al. Use of [18F]Fluorodeoxyglucose Positron Emission Tomography in Evaluating Locally Recurrent and Metastatic Adrenocortical Carcinoma J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2665 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Allolio and M. Fassnacht Adrenocortical Carcinoma: Clinical Update J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2027 - 2037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Bunyaviroch and R. E. Coleman PET Evaluation of Lung Cancer J. Nucl. Med., March 1, 2006; 47(3): 451 - 469. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Blake, J. M. A. Slattery, M. K. Kalra, E. F. Halpern, A. J. Fischman, P. R. Mueller, and G. W. Boland Adrenal Lesions: Characterization with Fused PET/CT Image in Patients with Proved or Suspected Malignancy--Initial Experience Radiology, March 1, 2006; 238(3): 970 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Metser, E. Miller, H. Lerman, G. Lievshitz, S. Avital, and E. Even-Sapir 18F-FDG PET/CT in the Evaluation of Adrenal Masses J. Nucl. Med., January 1, 2006; 47(1): 32 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D E Schteingart, G M Doherty, P G Gauger, T J Giordano, G D Hammer, M Korobkin, and F P Worden Management of patients with adrenal cancer: recommendations of an international consensus conference Endocr. Relat. Cancer, September 1, 2005; 12(3): 667 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Thorin-Savoure, F. Tissier-Rible, L. Guignat, A. Pellerin, X. Bertagna, J. Bertherat, and H. Lefebvre Collision/Composite Tumors of the Adrenal Gland: A Pitfall of Scintigraphy Imaging and Hormone Assays in the Detection of Adrenal Metastasis J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4924 - 4929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kumar, Y. Xiu, J. Q. Yu, A. Takalkar, G. El-Haddad, S. Potenta, J. Kung, H. Zhuang, and A. Alavi 18F-FDG PET in Evaluation of Adrenal Lesions in Patients with Lung Cancer J. Nucl. Med., December 1, 2004; 45(12): 2058 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pacak, G. Eisenhofer, and D. S. Goldstein Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography Endocr. Rev., August 1, 2004; 25(4): 568 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bagheri, A. H. Maurer, L. Cone, M. Doss, and L. Adler Characterization of the Normal Adrenal Gland with 18F-FDG PET/CT J. Nucl. Med., August 1, 2004; 45(8): 1340 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Minn, A. Salonen, J. Friberg, A. Roivainen, T. Viljanen, J. Langsjo, J. Salmi, M. Valimaki, K. Nagren, and P. Nuutila Imaging of Adrenal Incidentalomas with PET Using 11C-Metomidate and 18F-FDG J. Nucl. Med., June 1, 2004; 45(6): 972 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management Endocr. Rev., April 1, 2004; 25(2): 309 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Paulsen, H. V. Nghiem, M. Korobkin, E. M. Caoili, and E. J. Higgins Changing Role of Imaging-Guided Percutaneous Biopsy of Adrenal Masses: Evaluation of 50 Adrenal Biopsies Am. J. Roentgenol., April 1, 2004; 182(4): 1033 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al. American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003 J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Reed, D. H. Harpole, K. E. Posther, S. L. Woolson, R. J. Downey, B. F. Meyers, R. T. Heelan, H. A. MacApinlac, S.-H. Jung, G. A. Silvestri, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1943 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Vesselle, E. Turcotte, L. Wiens, and D. Haynor Application of a Neural Network to Improve Nodal Staging Accuracy with 18F-FDG PET in Non-Small Cell Lung Cancer J. Nucl. Med., December 1, 2003; 44(12): 1918 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Sarela, I. Murphy, D. G. Coit, and K. C. P. Conlon Metastasis to the Adrenal Gland: The Emerging Role of Laparoscopic Surgery Ann. Surg. Oncol., December 1, 2003; 10(10): 1191 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Khan, N Oriuchi, T Higuchi, H Zhang, and K Endo PET in the follow-up of differentiated thyroid cancer Br. J. Radiol., October 1, 2003; 76(910): 690 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Paci, G. Sgarbi, G. Ferrari, S. De Franco, and V. Annessi Controversies Over UICC-TNM Classification of Non-small Cell Lung Cancer : Model for a Diagnostic Path Chest, August 1, 2002; 122(2): 754 - 754. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
